May 16, 2017Open Access

Prevalence of Human Papillomavirus Among Females After Vaccine Introduction—National Health and Nutrition Examination Survey, United States, 2003–2014

SOSara E. OliverCenters for Disease Control and Prevention EUElizabeth R. UngerCenters for Disease Control and Prevention RLRayleen M. LewisCenters for Disease Control and Prevention

Key Points

Key points are not available for this paper at this time.

Abstract

Within 8 years of vaccine introduction, 4vHPV-type prevalence decreased 71% among 14- to 19-year-olds and 61% among 20- to 24-year-olds. Estimated vaccine effectiveness was high. The decrease in 4vHPV-type prevalence among unvaccinated females suggests herd protection.

Perguntar à IA

Bookmark

View Full Paper